- Home
- PTGX vs SCL Comparison
PTGX vs SCL Comparison
Compare PTGX & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- SCL
- Stock Information
- Founded
- PTGX 2006
- SCL 1932
- Country
- PTGX United States
- SCL United States
- Employees
- PTGX N/A
- SCL N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- SCL Package Goods/Cosmetics
- Sector
- PTGX Health Care
- SCL Consumer Discretionary
- Exchange
- PTGX Nasdaq
- SCL Nasdaq
- Market Cap
- PTGX 3.3B
- SCL 1.2B
- IPO Year
- PTGX 2016
- SCL N/A
- Fundamental
- Price
- PTGX $50.69
- SCL $58.84
- Analyst Decision
- PTGX Strong Buy
- SCL
- Analyst Count
- PTGX 9
- SCL 0
- Target Price
- PTGX $67.11
- SCL N/A
- AVG Volume (30 Days)
- PTGX 1.0M
- SCL 90.5K
- Earning Date
- PTGX 08-05-2025
- SCL 07-30-2025
- Dividend Yield
- PTGX N/A
- SCL 2.62%
- EPS Growth
- PTGX N/A
- SCL 47.62
- EPS
- PTGX 0.86
- SCL 2.45
- Revenue
- PTGX $207,801,000.00
- SCL $2,222,111,000.00
- Revenue This Year
- PTGX N/A
- SCL $8.56
- Revenue Next Year
- PTGX $47.15
- SCL $6.89
- P/E Ratio
- PTGX $58.76
- SCL $24.01
- Revenue Growth
- PTGX N/A
- SCL N/A
- 52 Week Low
- PTGX $32.50
- SCL $44.23
- 52 Week High
- PTGX $60.60
- SCL $94.77
- Technical
- Relative Strength Index (RSI)
- PTGX 44.36
- SCL 65.20
- Support Level
- PTGX $52.16
- SCL $54.28
- Resistance Level
- PTGX $57.24
- SCL $56.24
- Average True Range (ATR)
- PTGX 2.11
- SCL 1.45
- MACD
- PTGX -0.72
- SCL 0.28
- Stochastic Oscillator
- PTGX 11.25
- SCL 95.88
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About SCL Stepan Company
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.